Frontier Capital Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4M | Buy |
309,066
+200,249
| +184% | +$8.7M | 0.12% | 217 |
|
|
2025
Q1 | $4.07M | Sell |
108,817
-63,894
| -37% | -$2.39M | 0.04% | 260 |
|
|
2024
Q4 | $7.82M | Sell |
172,711
-138,605
| -45% | -$6.28M | 0.07% | 235 |
|
|
2024
Q3 | $18.3M | Buy |
+311,316
| New | +$18.3M | 0.17% | 177 |
|
|
2024
Q2 | – | Sell |
-76,481
| Closed | -$5.08M | – | 281 |
|
|
2024
Q1 | $5.08M | Buy |
+76,481
| New | +$5.08M | 0.05% | 246 |
|